Insmed Inc. buy JPMorgan Chase & Co.
Start price
07.02.25
/
50%
€77.50
Target price
07.02.26
€89.05
Performance (%)
93.55%
Price
30.12.25
€148.00
Summary
This prediction is currently active. With a performance of 93.55% the BUY prediction by JPMorgan_Chase___Co_ is a big success. This prediction currently runs until 07.02.26. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Insmed Inc. | 2.721% | 2.721% |
| iShares Core DAX® | 0.794% | 2.841% |
| iShares Nasdaq 100 | 0.016% | -0.939% |
| iShares Nikkei 225® | 0.309% | -0.648% |
| iShares S&P 500 | 0.181% | -0.442% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Insmed Inc. diskutieren
Insmed Incorporated (NASDAQ: INSM) had its price target raised by analysts at JPMorgan Chase & Co. from $83.00 to $92.00. They now have an "overweight" rating on the stock.
Ratings data for INSM provided by MarketBeat